Subsequent cell-type classification analysis using MCP-counter corroborated the stronger immune correlation of RNF220 in AML and identified decreased CD8+ T cells and increased endothelial cells in patients with high RNF220 expression (Figures 3g, h). This evidence concerns the gene CD8A and acute myeloid leukemia.